Skip to content
OpenCapital
Get started

Cyclerion Therapeutics CYCN Q1 2024 earnings

Reported March 25, 2026

Revenue$100.0KIn lineDiluted EPS-$0.38In line
Revenue estimate$100.0K
EPS estimate-$0.38

Next report

Aug 4, 2026 (In 3 weeks)
Revenue estimate$1.5M
EPS estimate-$7.10

Versus estimates

Revenue

Q4 2025$100.0KIn line
Q1 2024$100.0KIn line
Q3 2025$875.0KQ2 2025$93.0KQ1 2025$81.0K

Diluted EPS

Q1 2026-$0.76Beat by $16.44Q4 2025-$0.19Beat by $0.19
Q1 2024-$0.38In line
Q3 2025-$0.30Q2 2025-$0.11Q1 2025-$0.56

Ask the moment Cyclerion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cyclerion Therapeutics report Q1 2024 earnings?
Cyclerion Therapeutics (CYCN) reported Q1 2024 earnings on March 25, 2026.
What were Cyclerion Therapeutics's Q1 2024 revenue and EPS?
Cyclerion Therapeutics reported revenue of $100.0K and diluted EPS of $-0.38 for Q1 2024.
Did Cyclerion Therapeutics beat estimates in Q1 2024?
Revenue beat the consensus estimate of $100.0K by -. EPS beat the consensus estimate of $-0.38 by $0.00.
Where can I find Cyclerion Therapeutics's Q1 2024 SEC filings?
You can read the 10-Q periodic report (0000950170-24-054602) directly on SEC EDGAR. The filing index links above go to sec.gov.